Page last updated: 2024-10-26

2,3-dimethoxy-1,4-naphthoquinone and Sarcoma 180

2,3-dimethoxy-1,4-naphthoquinone has been researched along with Sarcoma 180 in 2 studies

2,3-dimethoxynaphthalene-1,4-dione : A naphthoquinone that is 1,4-naphthoquinone bearing two methoxy substituents at positions 2 and 3. Redox-cycling agent that induces intracellular superoxide anion formation and, depending on the concentration, induces cell proliferation, apoptosis or necrosis. Used to study the role of ROS in cell toxicity, apoptosis, and necrosis.

Sarcoma 180: An experimental sarcoma of mice.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kim, BH1
Yoo, J1
Park, SH1
Jung, JK1
Cho, H2
Chung, Y1
Song, GY1
Kim, Y1
You, YJ1
Ahn, BZ1

Other Studies

2 other studies available for 2,3-dimethoxy-1,4-naphthoquinone and Sarcoma 180

ArticleYear
Synthesis and evaluation of antitumor activity of novel 1,4-naphthoquinone derivatives (IV).
    Archives of pharmacal research, 2006, Volume: 29, Issue:2

    Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Screening A

2006
Naphthazarin derivatives (VII): antitumor action against ICR mice bearing ascitic S-180 cells.
    Archives of pharmacal research, 2001, Volume: 24, Issue:1

    Topics: Animals; Antineoplastic Agents; Drug Screening Assays, Antitumor; Male; Mice; Mice, Inbred ICR; Naph

2001